GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (XCNQ:NDAT) » Definitions » Common Stock

NDatalyze (XCNQ:NDAT) Common Stock : C$2.92 Mil (As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is NDatalyze Common Stock?

NDatalyze's quarterly common stock increased from Feb. 2024 (C$2.67 Mil) to May. 2024 (C$2.92 Mil) but then stayed the same from May. 2024 (C$2.92 Mil) to Aug. 2024 (C$2.92 Mil).

NDatalyze's annual common stock increased from Feb. 2022 (C$2.27 Mil) to Feb. 2023 (C$2.45 Mil) and increased from Feb. 2023 (C$2.45 Mil) to Feb. 2024 (C$2.67 Mil).


NDatalyze Common Stock Historical Data

The historical data trend for NDatalyze's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze Common Stock Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Common Stock
Get a 7-Day Free Trial 0.70 1.02 2.27 2.45 2.67

NDatalyze Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 2.69 2.67 2.92 2.92

NDatalyze Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


NDatalyze Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.
Executives
James Durward 10% Security Holder, Director, Senior Officer
Dwayne Albert Vinck Senior Officer

NDatalyze Headlines

No Headlines